{
    "clinical_study": {
        "@rank": "136290", 
        "arm_group": [
            {
                "arm_group_label": "commercially available nutrition supplement", 
                "arm_group_type": "Experimental", 
                "description": "this group receives a commercially available nutritional supplement for a period of 2 months"
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "this group receives a placebo for a period of 2 months"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomised controlled trial studies the effect of a commercially available nutritional\n      supplement on cholesterol levels in people with metabolic syndrome and elevated cholesterol\n      levels."
        }, 
        "brief_title": "The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Hypercholesterolaemia", 
        "condition_browse": {
            "mesh_term": "Hypercholesterolemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  metabolic syndrome according to ATPIII criteria 3 of the following:\n\n               -  waist circumference >88cm (in females) or >102cm (in males)\n\n               -  triglycerides >150mg/dl\n\n               -  HDL <40 (50)mg/dl in males (females)\n\n               -  blood pressure>130/85 or treatment for AHT\n\n               -  glucose >110mg/dl\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  treatment with cholesterol lowering drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065180", 
            "org_study_id": "verhoevenhermans"
        }, 
        "intervention": [
            {
                "arm_group_label": "commercially available nutrition supplement", 
                "description": "the food supplement contains red rice yeast and olive extract", 
                "intervention_name": "commercially available nutrition supplement", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "control group", 
                "intervention_name": "placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Antwerp", 
                    "country": "Belgium", 
                    "state": "Belgie", 
                    "zip": "2610"
                }, 
                "name": "University of Antwerp"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "LDL level", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "total cholesterol level", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "triglyceride level", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "HDL level", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065180"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universiteit Antwerpen", 
            "investigator_full_name": "Veronique Verhoeven", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "OxLDL", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "BMI", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "malondialdehyde (MDA)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "8-OH-deoxyguanosine (8-OHdG)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "side effects", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "waist circumference", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }
        ], 
        "source": "Universiteit Antwerpen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universiteit Antwerpen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}